Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre‐ibrutinib era: Incidence and risk factors

Chronic lymphocytic leukemia (CLL) patients are at increased risk for major hemorrhage (MH). We examined incidence of and risk factors for MH in CLL patients before introduction of newer CLL therapies such as ibrutinib, which includes bleeding risk. This study included 24 198 CLL patients treated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgantopoulos, Peter, Yang, Huiying, Norris, LeAnn B., Bennett, Charles L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536934/
https://www.ncbi.nlm.nih.gov/pubmed/30983123
http://dx.doi.org/10.1002/cam4.2134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536934/
https://www.ncbi.nlm.nih.gov/pubmed/30983123
http://dx.doi.org/10.1002/cam4.2134

Ejemplares similares